Roundtable Discussion: Communicating the Importance of Non-Coding RNA Therapeutics Compared to mRNAs to Investors

Time: 2:15 pm
day: Day Two

Details:

  • Outlining the advantages of different emerging non-coding RNAs in comparison to mRNAs
  • Unravelling different approaches of communicating the importance of non-coding RNA therapeutics to the industry
  • How can more interest be raised for investors?